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ABSTRACT
We previously found that CD8 T cells from IFN- gene knockout (GKO) donors induce more severe lethal
GVHD compared with CD8 T cells from wild-type (WT) donors in fully MHC-mismatched strain combina-
tions. In this study, we investigated the mechanisms by which IFN- inhibits GVHD in a parent¡ F1 (B6¡
B6D2F1) allogeneic HCT (allo-HCT) model. IFN- was strongly protective against GVHD in this parent ¡
F1 haplotype-mismatched allo-HCT model. Irradiated B6D2F1 mice that received GKO B6 CD4-depleted
splenocytes developed lethal GVHD with severe lung and liver injury, whereas those receiving a similar cell
population fromWT B6 donors survived long term. Donor CD8 cells showed rapid activation, accelerated cell
division, and reduced/delayed activation-induced cell death in allogeneic recipients in which donor cells were
incapable of producing IFN-. In consequence, the numbers of activated/effector (ie, CD25, CD62L, and
CD44high) donor CD8 T cells in the recipients of GKO allo-HCT significantly exceeded those in mice
receiving WT allo-HCT. These data show that IFN- negatively regulates the CD8 T cell response by
inhibiting cell division and promoting cell death and suggest that blockade of IFN- could augment the severity
of GVHD in patients undergoing allo-HCT.
© 2007 American Society for Blood and Marrow Transplantation
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HNTRODUCTION
IFN- is a potent proinﬂammatory cytokine that
lays important and complex roles in innate and adap-
ive immune responses. The compromised immunity
o multiple intracellular pathogens in IFN-- and
FN- receptor-deﬁcient mice suggests an important
ole for IFN- in the induction of cellular immune
esponses [1,2]. A recent study using IFN- receptor-
eﬁcient mice showed that IFN- acts directly on
D8 T cells to stimulate the development of CTL
esponses after lymphocytic choriomeningitis virus in-
ection [3]. However, increasing evidence has demon-
trated that IFN- may also downregulate immune
esponses. IFN- plays an important role in the main-
enance of T cell homeostasis and eliminates activated [
6D4 [4-8] and CD8 [8-10] T cells by inducing apo-
tosis. It has been shown that IFN- promotes cell
eath of activated T cells [11-14]. IFN- has also been
eported to facilitate induction of long-term allograft
urvival by blockade of T cell costimulation pathways
15]. Further, recent studies have shown that IFN- is
equired for the function of alloantigen-speciﬁc reg-
latory T cells [16] and may inhibit CD8 memory T
ell generation [17]. Although the mechanisms remain
argely unknown, these studies indicate that IFN-
as a complex role in the regulation of immune re-
ponses.
Activated T cells produce IFN- and the level of
FN- in patients undergoing allogeneic HCT (allo-
CT) may reﬂect ongoing GVH allogeneic responses18-21]. Such a correlation between high levels of
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IFN- Inhibits CD8 T Cell Alloreactivity In Vivo 47FN- and severe GVHD has led to a suggestion that
FN- may be involved in the pathogenesis of
VHD. Of note, this cytokine has been reported to
ontribute to gut injury [22,23] and lymphoid hyp-
plasia [24,25] in patients after allo-HCT. However,
tudies using anti-IFN- antibody and IFN- gene
nockout (GKO) mice have demonstrated that this
ytokine can inhibit the development of acute GVHD
y promoting apoptosis of alloreactive CD4 T cells
26-29].
We recently observed that IFN--deﬁcient CD8
cells induce more severe GVHD than do wild-type
WT) cells in fully MHC- plus minor antigen-mis-
atched allogeneic recipients [30]. In the present
tudy, we explored the mechanisms of the regulation
f alloreactive CD8 T cells by IFN- using a clinically
elevant, parent ¡ F1, allo-HCT model. We ob-
erved that IFN- plays a critical role in controlling
onor CD8 T cell activation, proliferation, and sur-
ival in patients after allo-HCT. In the absence of
FN-, activation and expansion of alloreactive donor
D8 T cells was signiﬁcantly augmented and apopto-
ic cell death of such cells was markedly reduced,
esulting in increased accumulation of highly divided
onor CD8 T cells. Further, IFN--deﬁcient, but not
T, donor CD8 T cells induced lethal GVHD char-
cterized by severe damage to nonlymphoid target
issues.
ETHODS
nimals
Female WT C57BL/6 mice (B6; H-2b), IFN-
KO mice on the B6 background (B6.129S7-
fngtm1Ts; H-2b), and B6D2F1 (H-2bd) mice were
urchased from The Jackson Laboratory (Bar Harbor,
e). Anti-Ld 2C TCR transgenic mice on the B6
ackground were generously provided by Dr Dennis
. Loh [31]. IFN--deﬁcient 2C TCR transgenic
GKO 2C) mice on the B6 background were gener-
ted as previously described [30]. Mice were housed in
speciﬁc pathogen-free microisolator environment
nd fed autoclaved feed and autoclaved acidiﬁed wa-
er. Protocols involving animals were approved by the
assachusetts General Hospital subcommittee on re-
earch animal care.
able 1. Pathologic GVHD Criteria
Colon
rypt epithelial cell regeneration, apoptosis Perivascu
rypt loss Peribronc
urface colonocyte attenuation
nflammatory cell infiltrate
ucosal ulceration
hickness of mucosallo-HCT and Induction of GVHD
Recipient B6D2F1 mice were lethally irradiated
9.75 Gy) and reconstituted within 4-8 hours with 7
06 T cell (ie, CD4 and CD8)-depleted (TCD) BM
ells (BMCs) and 3  107 CD4-depleted spleen cells
rom WT or GKO B6 mice or with 5  106 BMCs
nd 1.5  107 spleen cells from 2C or GKO 2C B6
ice. Mice that received TCD BMCs and TCD
plenocytes from allogeneic donors were used as non-
VHD controls. CD4- and CD8-depleted cells were
repared with anti-CD4 or CD8 microbeads fol-
owed by negative selection using the MACS separa-
ion system according to the manufacturer’s protocol
Miltenyi Biotec, Auburn, Calif).
istopathology
GVHD target tissues (liver, lungs, and colon) were
arvested at various times after HCT and ﬁxed in
ouin solution or 10% formalin. Parafﬁn sections
ere prepared and stained with H&E. Pathologic
VHD was evaluated by a pathologist (R Bronson)
ithout knowledge of the treatment the animals re-
eived based on the parameters listed in Table 1. Each
arameter was scored using a score system ranging
rom 0 to 4: 0, normal; 0.5, focal and rare; 1, focal and
ild; 2, diffuse and mild; 3, diffuse and moderate; and
, diffuse and severe.
low Cytometric Analysis
To determine T cell activation, single-cell suspen-
ions were prepared from spleen and lymph nodes and
tained with ﬂuorescent (FITC or PE)-conjugated
Ab speciﬁc for activation/memory markers (CD25,
D44, and CD62L) and anti-CD8 mAb. NKT
NKT) cells and subsets were identiﬁed by staining
he cells with FITC-conjugated anti-CD3, PE-conju-
ated anti-NK1.1, plus APC-conjugated anti-CD4
nd/or CD8. Treg cells were determined by an APC-
onjugated anti-Foxp3 mAb (eBioscience, San Di-
go, Calif). In patients after allo-HCT, donor cells
ere identiﬁed by staining with biotinylated anti-
-2Dd mAb 34-2-12 [32] developed with PE-
treptavidin or streptavidin-allophycocyanin. Non-
peciﬁc FcR binding was blocked with anti-mouse
cR mAb 2.4G2. Exclusion of dead cells was per-
g Liver
infiltrate Portal tract inflammatory cell infiltrate
cell infiltrate Bile duct lymphocytic infiltrate
Vascular endothelialitis
Parenchymal apoptosis
Parenchymal microabscessesLun
lar cell
hiolarParenchymal mitotic figures
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W. Asavaroengchai et al.48ormed by propidium iodine staining and live gating
n propidium iodine-negative cells. Nonreactive
ITC-conjugated and biotinylated mouse IgG2a mAb
OPC-1, PE- and allophycocyanin-labeled rat IgG2a
Abs were used as negative controls. In proliferation
tudies, donor spleen cells were incubated with 1 M
FSE (Molecular Probes, Eugene, Ore) at 50  106
ells/mL for 15 min at 37°C in the dark. Cold medium
ith 2% FCS was added to stop the labeling reaction.
ells were then washed twice with fresh serum-free
edium and resuspended at desired concentrations
efore transplantation. In apoptotic studies, cells were
tained with APC-conjugated Annexin V and amino-
ctinomycin D. Apoptotic cells were deﬁned by An-
exin V-positive and aminoactinomycin D-negative
opulation. Unless otherwise indicated, all antibodies
sed were purchased from BD PharMingen (San Di-
go, Calif).
tatistical Analysis
Statistical analysis of survival data was performed
ith the log-rank test. The Student t test was used to
etermine the level of signiﬁcance of differences in
roup means. P  .05 was considered statistically
igniﬁcant in both types of analysis.
ESULTS
FN--deficient CD8 T Cells Induce Acute
ethal GVHD
To determine the role of IFN- in CD8-mediated
VHD, B6D2F1 mice were lethally irradiated and
econstituted with 7  106 TCD BMCs and 30  106
D4-depleted spleen cells from WT or GKO B6
ice through the tail vein. As shown in Figure 1A,
llo-HCT from GKO donors induced severe lethal
igure 1. IFN- inhibits GVHD induced by donor CD8 T cells. R
06 TCD BMCs and 3  107 CD4-depleted spleen cells from W
on-GVHD controls were lethally irradiated B6D2F1 mice that re
 8) or GKO (GKO-Ctrl; n  8) donors. Data from 3 independe
KO allo-HCT inocula (ie, CD4-depleted splenocytes) used in the
3%, respectively. Shown are (A) percent survival and (B) mean bod
hanges  [(current weight/weight at day 0)  1]. *P  .05.VHD, with 50% (10 of 19) mortality by 3 wk and H00% mortality by 6 wk (P  .01 versus recipients of
T allo-HCT). These mice developed severe clinical
igns of acute GVHD, including massive weight loss
Figure 1B), rufﬂed fur, hunched posture, and diar-
hea before death. In contrast, most mice (12 of 15)
eceiving a similar HCT inoculum from WT B6 do-
ors survived long term. The recipients of WT allo-
CT showed only moderate (10%) weight loss dur-
ng the ﬁrst week and gradually gained the weight
ack (Figure 1B). Control mice that received TCD
llogeneic cells from WT or GKO B6 mice appeared
ealthy throughout the experiment (Figure 1). These
esults demonstrate that IFN- mediates signiﬁcant
rotection against GVHD induced by CD8 T cells in
1 recipients of allo-HCT from parental donors, con-
istent with previous observations in fully MHC-mis-
atched strain combinations [30].
ncreased Pathologic GVHD in Recipients of
KO Allo-HCT
Histologic examination was performed on tissues
repared from the recipient mice at days 2, 4, 5, 7, and
1 after HCT, and pathologic changes were scored
lindly. WT and GKO allo-HCT groups showed
inimal pathologic changes in lungs and liver at days
(not shown) and 4 (Figure 2A,B). By day 7 after
CT, severe inﬂammatory inﬁltrates were seen in the
ungs and liver in the recipients of GKO allo-HCT,
hereas signiﬁcant inﬂammatory inﬁltrates were not
etected in the same tissues from the recipients of
T allo-HCT until day 11 after HCT. Pathologic
VHD scores for both tissues harvested at days 5 and
were signiﬁcantly higher in the recipients of GKO
llo-HCT than in those receiving WT allo-HCT
Figure 2A,B). Further, the recipients of GKO allo-
t B6D2F1 mice were lethally irradiated and reconstituted with 7 
GVHD; n  15) or GKO (GKO GVHD; n  19) B6 donors.
TCD BMC alone or with TCD splenocytes from WT (WT-Ctrl;
riments are combined. The percentages of CD8	 cells in WT and
eriments were 17.9% and 17.7%, 16.1% and 15.7%, and 21% and
t changes (mean 
 SDs) of the allo-HCT recipients. Mean weightecipien
T (WT
ceived
nt expe
se exp
y weighCT showed markedly increased inﬁltration by CD8
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IFN- Inhibits CD8 T Cell Alloreactivity In Vivo 49cells in the liver compared with mice receiving WT
llo-HCT (Figure 2D).
During the acute phase of GVHD progression,
athologic changes in the intestine included crypt
estruction and mucosal alterations [33]. As shown
n Figure 2C, by day 5 after HCT, the recipients of
KO allo-HCT developed severe colonic GVHD,
s demonstrated by massive inﬂammatory cell inﬁl-
rates, crypt regeneration, epithelial cell apoptosis,
igure 2. GKO allo-HCT induces more severe GVHD pathology.
hown are pathologic GVHD scores (mean 
 SD, n  3-6/group)
nd representative H&E photomicrographs of the lungs (A), liver
B), and colon (C) from the recipients of WT allo-HCT (solid
olumns) or GKO allo-HCT (open columns). *P  .05. D, Immu-
oﬂuorescent staining of liver sections prepared from allo-HCT
ecipients at day 7 with anti-CD8. Three mice from each group
ere analyzed and representative photomicrographs are shown.
able 2. Numbers of Donor CD8 T Cells in the Spleen of Allo-HCT R
Experiment
Day 4
WT GKO P WT
1 1.0  0.2 1.4  0.2 >.05 3.8  0
2 0.7  0.04 1.4  0.1 <.05 3.9  0
3 2.0  0.4 7.1  0.7 <.01 6.2  1
/A indicates not available.
The number of donor CD8 T cells per spleen was determined by
cytometric analysis and the total number of spleen cells harveste
per spleen (n  3/group in all 3 experiments).urface colonocyte attenuation, and thickening of
ucosa. Colonic GVHD in these recipients de-
reased after day 5 and subsided by day 11. Al-
hough a similar pathologic pattern was also seen in
he recipients of WT allo-HCT, its development
as delayed compared with that in recipients of
KO allo-HCT.
ugmented Activation and Expansion of Donor
D8 T Cells in Recipients of GKO Allo-HCT
To determine the mechanisms by which IFN-
eﬁciency augments GVHD, we compared the acti-
ation and expansion of donor CD8 T cells in the
pleens of lethally irradiated B6D2F1 mice that re-
eived TCD BMCs plus CD4-depleted splenocytes
rom WT or GKO B6 donors. The numbers of total
onor CD8 T cells in the spleens of the recipients of
KO allo-HCT were signiﬁcantly larger at days 4 and
but became similar or lower at day 7 than that in
ecipients of WT allo-HCT (Table 2). Because T
ells gain CD25 expression and lose CD62L expres-
ion upon activation, we also compared the expression
f these molecules on donor CD8 T cells. As shown in
igure 3A,B, the percentages of CD25	 and CD62
onor CD8 T cells in the recipients of GKO allo-
CT were markedly greater than those in recipients
f WT allo-HCT, suggesting an increased activation
n the absence of IFN-. Further, GKO donor CD8 T
ells acquired a “memory” phenotype (ie, CD44high
nd CD45RBlow) more rapidly than did WT donor
D8 T cells in allo-HCT recipients (Fig. 3A,B, and
ata not shown). Because nearly all GKO donor CD8
cells lost expression of CD62L, a secondary lym-
hoid organ homing receptor [34], by day 5, and
ncreased CD8 T cell inﬁltration was detected in the
VHD target tissues in the GKO allo-HCT group
Figure 2D); the reduction in donor CD8 T cells
etected at day 7 in mice receiving GKO allo-HCT
Table 2) might be due in part to more rapid trafﬁck-
ng of activated CD8 T cells to GVHD target tissues.
We also performed a similar analysis in a 2C TCR
ransgenic allo-HCT model. The 2C cytotoxic T cell
lone was derived from mice with H-2b that were
mmunized with H-2d cells [35]. Because most T cells
n 2C TCR transgenic mice are CD8	2C TCR	 cells
s at Indicated Times*
Day 5 Day 7
GKO P WT GKO P
11.8  2.5 <.05 28.4  1.7 26.4  1.3 >.05
18.1  1.3 <.001 N/A N/A N/A
11.9  2.7 >.05 15.0  0.7 7.1  1.3 <.01
roduct of the percentage of donor CD8 T cells measured by ﬂow
each animal, and data are presented as group means 
 SDs (106)ecipient
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W. Asavaroengchai et al.50hat speciﬁcally recognize H-2Ld, administration of
C T cells into H-2Ld	 mice allows the study of
VH reactivity of CD8 T cells. Lethally irradiated
9.75 Gy) B6D2F1 mice received 5 106 TCD BMCs
nd 15  106 spleen cells from WT 2C or GKO 2C
CR transgenic B6 mice. The percentages of CD25	
nd CD62L 2C CD8 T cells were signiﬁcantly
igher in the B6D2F1 mice receiving GKO 2C cells
han in those receiving WT 2C cells (Figure 3C).
ogether, these results indicate that the activation and
xpansion of GVH-reactive CD8 T cells are signiﬁ-
antly increased in allo-HCT recipients when the do-
or cells are deﬁcient in IFN- production.
ole of IFN- in Apoptosis and Cell Division of
lloreactive Donor CD8 T Cells
The total number of activated donor CD8 T cells
ould be determined by the combined effects of acti-
ation-induced cell death and cell division. When we
ssessed apoptosis of donor CD8 T cells in the recip-
igure 3. Augmented activation and expansion of donor CD8 T c
arkers on donor CD8 T cells in the spleens of lethally irradiated
/group). A, Percentages of donor CD25	, CD62L, and CD44hig
ells are presented as solid and open bars, respectively. B, Represent
D44 on gated donor CD8 T cells at day 4. Thick lines represen
roﬁles of appropriate isotype control mAs and naive splenocytes
repared from B6D2F1 recipients of allo-HCT from WT (solid ba
ercentages of CD25	 and CD62L 2C T cells were analyzed by ﬂo
05; **P  .01.ent spleens in the B6¡ B6D2F1 (Fig. 4A) and 2C¡ C6D2F1 (Figure 4B) models, we observed that donor
D8 T cell apoptosis was markedly reduced/delayed
n the recipients of GKO allo-HCT compared with
hose receiving WT allo-HCT. In the B6¡ B6D2F1
odel, GKO donor CD8 T cell apoptosis was signif-
cantly reduced at earlier times, at days 4 and 5, but
ncreased by day 7 (Fig. 4A). The later increase in
poptosis of GKO donor CD8 T cells may also con-
ribute to the reduction in donor CD8 T cells in the
pleen detected at day 7 in mice receiving GKO allo-
CT (Table 2). In the 2C ¡ B6D2F1 allo-HCT
odel, signiﬁcantly reduced apoptosis was detected at
ay 3 in GKO 2C T cells compared with WT 2C T
ells (Fig. 4B).
To assess donor CD8 T cell division in allo-
CT recipients, lethally irradiated B6D2F1 mice
eceived TCD BMCs and CFSE-labeled CD4-de-
leted spleen cells from WT or GKO B6 donors.
pleen and lymph node cells were prepared from
he recipients at days 2 and 4 and analyzed for donor
the recipients of GKO allo-HCT. A, B, Expression of activation
F1 mice receiving allo-HCT from WT or GKO B6 donors (n 
T cells at the indicated time points. WT and GKO donor CD8 T
w cytometric proﬁles display the expression of CD25, CD62L, and
otype staining controls. Analysis gates were set based on staining
ained with the same mAbs at the same time. C, Spleen cells were
GKO (open bars) 2C donors at the indicated time points, and the
metric analysis. Data are shown as mean
 SD (n 3/group). *Pells in
B6D2
h CD8
ative ﬂo
t the is
were st
rs) or
w cytoD8 T cell divisions by ﬂow cytometry. As shown
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IFN- Inhibits CD8 T Cell Alloreactivity In Vivo 51n Figure 5A,B, the numbers of dividing donor CD8
ells, especially those with extensive cell divisions
8 divisions), were signiﬁcantly increased in the
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BA
igure 4. Effect of IFN- on apoptosis of donor CD8 T cells.
pleen cells were prepared from the recipients of WT (solid bars) or
KO (open bars) allo-HCT at the indicated time points, and the
ercentages of apoptotic donor CD8 (or 2C) T cells were deter-
ined by ﬂow cytometric analysis. A, Percentages of apoptotic
onor CD8 T cells in the spleens of B6 ¡ B6D2F1 HCT recipi-
nts. B, Percentages of apoptotic donor 2C T cells in the spleens of
C ¡; B6D2F1 HCT recipients. Data are shown as mean 
 SD
n  3-6/group). *P  .05; **P  .01.
igure 5. Effect of IFN- on division of donor CD8 T cells. A, B, B
rom WT (solid bars) or GKO (open bars) B6 donors (n  3/grou
ime points and analyzed for division of donor CD8 T cells. A, Num
and in the lymph nodes at day 4 after HCT. Axillary, brachial, an
ooled lymph node cells were analyzed. B, Representative histogram
ercentages of cells with each number of cell divisions. C, B6D2F1
r GKO (open bars) 2C donors (n  3/group). Data shown are perc
n the recipient spleen at day 4 after HCT. *P  .05; **P  .01; ***P  .ice receiving GKO allo-HCT compared with the
ecipients of WT allo-HCT.
Because of the presence of non-GVH-reactive
D8 T cells in the allo-HCT inoculum, it was difﬁ-
ult to conclude if the increased number of extensively
ivided donor CD8 T cells was due to augmented cell
roliferation and/or reduced apoptosis of dividing do-
or T cells. Thus, we next compared cell division
etween GKO and WT 2C T cells in the 2C ¡
6D2F1 allo-HCT model. Similar to the B6 ¡
6D2F1 model, the numbers of host-reactive 2C T
ells with 7 divisions were signiﬁcantly larger in the
ecipients of GKO allo-HCT than in mice receiving
T allo-HCT (Figure 5C). However, the numbers of
C T cells with 4 divisions were lower in mice
eceiving GKO allo-HCT than in those receiving
T allo-HCT (Figure 5C). Because GKO 2C T cells
howed reduced apoptosis in allo-HCT recipients
ompared with WT 2C T cells (Figure 4B), the re-
uction in less divided GKO 2C T cells and the
ncrease in GKO 2C T cells with7 divisions is likely
consequence of accelerated proliferation of these
mice received BMCs and CSFE-labeled CD4-depleted spleen cells
ipient spleen and lymph node cells were prepared at the indicated
f donor CD8 T cells with each division in the spleen at days 2 and
inal lymph nodes were harvested at the indicated time points, and
CFSE levels in gated donor CD8 T cells at day 4. Numbers indicate
ceived BMCs and CFSE-labeled spleen cells from WT (solid bars)
of donor 2C TCR	 cells with different cell divisions (mean 
 SD)6D2F1
p). Rec
bers o
d ingu
s show
mice re
entages001.
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W. Asavaroengchai et al.52ells. Together, these results indicate that IFN- pro-
otes apoptosis and limits the proliferation of donor
D8 T cells in allo-HCT recipients.
-reg, NKT, and Memory T Cell Contents in
T and GKO Mice
To determine whether the different ability to in-
uce GVHD between WT and GKO allo-HCT
ight be attributable to differences in the contents of
arious T cell subsets in the HCT inocula, we com-
ared the levels of Treg, NKT, and memory T cells in
he spleen between WT and GKO B6 mice. In both
roups, almost all splenic Treg (ie, CD3	Foxp3	)
ells expressed CD4 (Figure 6A). The level of
D4	Foxp3	 Treg cells (most of these cells also
xpress CD25) was signiﬁcantly lower in the spleen of
KO mice compared with WT mice. However, the
evels of CD4 (including CD8	) cells expressing
oxp3 were comparable between WT and GKO mice
nd both were extremely low. Further, the levels of
plenic CD4 and CD8 NKT (ie, CD4	CD3	NK1.1	
nd CD8	CD3	NK1.1	) cells were similar between
T and GKO mice, but more double-negative NKT
ie, CD4CD8CD3	NK1.1	) cells were detected in
he latter group (Figure 6B).
Interestingly, GKO mice showed a signiﬁcant in-
rease in CD8 T cells with an effector memory phe-
otype (ie, CD44	CD62L) compared with WT
ice (Figure 6C), consistent with the increase of al-
oreactive CD8 memory T cells in allo-HCT recipi-
nts (Figure 3). No signiﬁcant difference was detected
etween WT and GKO mice in other memory T cell
ubsets, including CD4 and CD8 central memory (ie,
D44	CD62L	) T cells and CD4	 effector memory
cells. Because memory T cells are markedly less
otent than naive T cells in inducing GVHD [36-39],
igure 6. Comparison of Treg, NKT, and memory T cells in nor
solid bars) and GKO (open bars) B6 mice (8 wk old; n  3/group
, Percentages of total (CD3	Foxp3	), CD4 (CD4	Foxp3	), CD8
otal (CD3	NK1.1	), CD4 (CD4	CD3	NK1.1	), CD8 (CD8	C
ells. C, Percentages of CD4 and CD8 central (CD44	CD62L	)
ean 
 SD. *P  .05; **P  .01.he higher incidence of GVHD observed in the recip- ments of GKO allogeneic cells is unlikely to be due to
he inclusion of more CD8 effector memory T cells in
he HCT inoculum.
ISCUSSION
This study provides evidence that IFN- plays a
ritical role in the regulation of CD8 T cell alloreac-
ivity in vivo. Allo-HCT recipients of GKO CD8 cells
eveloped severe acute GVHD and succumbed to
eath within 6 wk, whereas most of the mice receiving
imilar allo-HCT from WT donors survived long
erm (Figures 1 and 2). The augmented GVHD in
ecipients of GKO allo-HCT was associated with
arkedly increased expansion of alloreactive donor
D8 T cells. It has been reported that IFN- stimu-
ates death of antigen-speciﬁc CD8 T cells in a Listeria
nfection model [14]. Our results demonstrate that
FN- also promotes death of alloreactive CD8 T
ells in vivo, and that the increased donor CD8 T cell
xpansion and augmented GVHD in the recipients of
KO allo-HCT was, at least in part, due to the
educed/delayed death of host antigen-activated do-
or CD8 T cells.
IFN- appears to regulate a critical checkpoint of
cell proliferation. T cell proliferation is governed by
he ordered activation of cyclin-dependent kinases
CDKs) [40]. Studies using gene-targeted knockout
ice and transgenic mice have demonstrated that the
DK inhibitor, p27Kip1, plays a critical role in con-
rolling T cell proliferation, and the lack of p27Kip1
xpression results in a signiﬁcant increase in T cell
umbers [41,42]. A recent study has shown that naive
D8 T cells have high expression of p27Kip1 and low
DK6 and CDK2 kinase activity, whereas G0/G1
T and GKO B6 mice. Spleen cells were prepared from naive WT
nalyzed for Treg, NKT, and memory T cells by ﬂow cytometry.
Foxp3	), and CD4 (CD4Foxp3	) Treg cells. B, Percentages of
K1.1	), and double-negative (CD4CD8CD3	NK1.1	) NKT
ector (CD44	CD62L) memory T cells. Results are presented asmal W
) and a
(CD8	
D3	N
and effemory CD8 T cells have low expression of p27Kip1
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IFN- Inhibits CD8 T Cell Alloreactivity In Vivo 53nd high CDK6 kinase activity, and the latter favors
apid cell division [43]. Further, IFN- has been
hown to inhibit the proliferation of bronchial epithe-
ial cells by preventing growth factor-induced down-
egulation of p27Kip1 [44]. However, relatively little is
nown about the role of IFN- in regulating in vivo
roliferation of activated CD8 T cells. In the present
tudy, we observed that cell division rates and num-
ers of donor CD8 cells were markedly increased in
he recipients of GKO allo-HCT compared with
hose in mice that received WT allo-HCT. Using the
C allo-HCT model that allows speciﬁc assessment of
he host-reactive CD8 T cells, we found that the lack
f IFN- results in marked increases in the numbers
f host MHC-reactive 2C T cells with 7 divisions,
hich was associated with a signiﬁcant decrease in the
umbers of less divided 2C T cells (Figure 5C). These
esults indicate that IFN- plays an important and
reviously unidentiﬁed role in controlling the prolif-
ration of activated CD8 T cells in vivo, and that the
ack of this cytokine accelerates the division of host
ntigen-reactive donor CD8 T cells in allo-HCT re-
ipients. Because type 1 T cells, which are capable of
roducing IFN-, do not respond to IFN- due to the
oss of IFN- receptor 2 expression [45,46], the role of
FN- in regulating cell division of host antigen-
ctivated T cells might be mediated by an indirect
echanism. A recent study has shown that CD11b	
ells responding to IFN- can limit CD8 T cell
xpansion and promote contraction of this popula-
ion [47].
Histologic examinations revealed that mononu-
lear cell inﬁltration and tissue injury in GVHD target
issues was more severe in the recipients of GKO
llo-HCT than in those that received WT allo-HCT.
t is likely that the augmented donor T cell activation
nd expression due to reduced apoptosis and acceler-
ted proliferation in the recipients of GKO allo-HCT
ay result in an overall increase in donor T cell
nﬁltration in GVHD target tissues. The accelerated
eneration of effector/memory T cells in the recipi-
nts of GKO allo-HCT might also contribute to the
apid and severe tissue injury in these mice. Recently,
FN- has been shown to inhibit CD8 memory T cell
eneration in mice after dendritic cell vaccination
17]. In this study, we observed that the ratio of CD8
ffector memory (CD8	CD44	CD62L) T cells in
he spleen was signiﬁcantly greater in GKO mice than
n WT mice (Figure 6C). Further, GKO donor CD8
cells lose CD62L expression more rapidly than WT
D8 T cells upon activation, and almost all donor
D8 T cells in the spleens of mice receiving GKO
llo-HCT acquired an effector memory phenotype
CD62LCD44	) by day 5 after HCT (Figure 3).
hese results indicate that the egress of activated
onor CD8 T cells from lymphoid tissues may occur
arlier in the recipients of GKO allo-HCT. The data clso suggest that the absence of IFN- might provide
onditions favoring the differentiation and/or expan-
ion of CD8 effector memory T cells in allo-HCT
ecipients.
Treg cells have been shown to protect against
VHD [48,49]. Although IFN- plays an important
ole in the generation and function of CD4 Treg cells
Figure 6A) [16], the lack of this cytokine does not lead
o reduction in CD4 Treg cells in the spleen
Figure 6A). Further, the level of CD4 Treg cells
n the spleen is extremely low in WT and GKO mice.
ecause CD4-depleted allo-HCT was the procedure
n our studies, these results suggest that the difference
n GVHD between the recipients of WT and GKO
llo-HCT was unlikely due to the difference in Treg
ell contents in the donor inocula. NKT cells have
lso been shown to induce allograft tolerance [50] and
nhibit GVHD [51,52]. IFN- seems to play an im-
ortant role in NKT-induced allograft tolerance [50],
ut the GVHD-inhibitory effect of NKT cells has
een shown to be dependent on their production of
nterluekin-4 [51]. Our results show that GKO mice
ave more CD4CD8 NKT cells in the spleen than
T mice (Figure 6B). Further functional analysis is
eeded to ﬁrmly determine the role of NKT cells in
FN--mediated inhibition of GVHD.
IFN- is produced by multiple cell types, includ-
ng type 1 T cells, NK/NKT cells, and dendritic cells
DCs) [53-56]. Recent studies have demonstrated that
novel DC subset, IFN-producing killer DCs
IKDCs), also produce IFN- [57,58]. These cells
ould serve as the major source of IFN- in some
umor models where the tumor cells are poorly rec-
gnized by NK cells [58]. However, the role of
KDCs in regulating allogeneic responses remains un-
nown. The present study demonstrates that donor-
erived IFN- protects against GVHD, but has not
dentiﬁed the sources of donor IFN- that mediate
he protective effect.
In summary, our results demonstrate that IFN- is
n important regulatory cytokine during CD8 T cell
ctivation in vivo. This cytokine inhibits the activation
nd expansion of donor CD8 T cells by promoting
ell death and suppressing cell division and downregu-
ates effector/memory CD8 T cell generation in allo-
CT recipients. Importantly, this cytokine mediates
raft-versus-leukemic effects while inhibiting GVHD
30]. Our recent studies have indicated that IFN- is
equired for the optimal induction of GVH reactions
hat preferentially attack the host lymphohematopoi-
tic cells (Wang H et al, manuscript in preparation),
hich has been shown to mediate graft-versus-leuke-
ic effects without severe GVHD [59,60]. Further
nderstanding of the molecular mechanisms involved
n regulating T cell alloreactivity by IFN- will likely
hed new light on the development of strategies in
linical GVHD prevention and therapy.
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